chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient notified Vaccine Coordinator on 4/7/2021 that when she received her first dose of Moderna COVID-19 vaccine on 2/3/2021, she had immediate sharp pain while the vaccine was being injected into her right arm.  She stated that the injection site remained extremely painful and that she was not able to use her arm for the next 2 days, and only had slight improvement in range of motion over the next week.  She received her second dose of Moderna COVID-19 vaccine on 3/4/2021 and did not have the same immediate pain in her left arm, but reported she didn?t even feel the vaccine being administered.  She stated that she had some minor general arm soreness in her left arm after the two days following administration of 2nd dose, and then it resolved and did not interfere with her range of motion or use of her left arm.  She scheduled an appointment with her primary Medical Doctor to check on her right arm, and had an appointment on 4/2/2021.  Her primary MD ordered an MRI of her right arm/shoulder, which was completed on 4/5/2021.  She told Vaccine Coordinator that she will have a follow up consult with an Orthopedist and will need Physical Therapy for her right arm.  She is confident this will resolve with time and therapy and was not upset, but stated she would rather deal with a sore arm than with contracting COVID-19 disease.  Vaccine Coordinator did recommend that she also fill out a VAERS report with details concerning her symptoms.
Swollen lymph nodes in left armpit. Bruising at site of injection. Bruising and swelling happened same day as dose #2. Advil taken to alleviate symptoms, but side effects still occurring on 2/5.
After pt received flu vaccine, went with parents to checkout.  While mom talking with dental management support staff, child falls, hits head, mom thought child had what looked like seizure as soon as nursing arrived no seizure activity noted.
Dizziness and Nausea at 10:00; Given crackers and juice since pt reports not eating breakfast; 1015 vital signs stable; 1020 reports clammy hands, dizziness, and nausea, but rest of skin is pink, warm and dry and pt denies SOB and lightheadedness; 1027 escorted to ER for further evaluation since sx's did not resolve.
Joint pain; Knees swelled; Headache(less severe); Migraine; Nausea; Flash hot; Leg pain; Dizziness; Sinus running; chills; Fatigue; This is a spontaneous report from a contactable consumer, the patient. This is the first of two cases. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in left arm on 09Mar2021 at 09:30 (at the age of 62-years-old) and received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in left arm on 30Mar2021 at 09:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included undiagnosed pain in legs and lyme disease. The patient was allergic to most narcotic pain meds (unspecified). Concomitant medications included baclofen (MANUFACTURER UNKNOWN) 5mg, gabapentin (MANUFACTURER UNKNOWN) 300 mg and eyedrops for glauc (unspecified). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Worst first dose than second, on 09Mar2021 (1st day), the patient experienced migraine, nausea, hot flashes, leg pain, dizziness, sinus running, chills and fatigue. On 10Mar2021 (2nd day) joint pains, knees swelled, headaches (less severe). On 11Mar2021 (3rd day), nausea, dizziness, fatigue. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments were not taken as a result of the events. The clinical outcome of the events migraine, nausea, hot flashes, leg pain, dizziness, sinus running, chills, fatigue, joint pain, knee swelled and headache were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Chills started around 11:30pm on 4/2/21; woke with fever, aches and sweats at 3am on 4/3/21.  Fever, aches and fatigue persisted throughout 4/3/21.  Took tylenol to manage fever and pain.  Most symptoms had subsided by by mid-day on 4/4, but aches and fatigue persisted.  Woke up on 4/5 feeling fine.
Vaccine given 5/4/15, reaction noted 5/6; warmth/erythematous about the size of a nickle, observed and on 5/7 noted that reaction area a little worse. Diphenhydramine 25mg oral given and cephalexin 500mg tid x7d.
rash over 50% of body. Never have experienced anything like this before except maybe when I had the measles as a child. First noticed morning of 1/28/2021. rash is red with small bumps, slightly itchy in one or 2 places at time of reporting. Right now, very mild symptoms
DOSES THAT WERE ADMINISTERED MORE THAN 6 HOURS AFTER THE VIAL WAS FIRST PUNCTURED/ SUBSEQUENT DOSES WERE ADMINISTERED SEVERAL DAYS LATER; VACCINE WAS STORED MORE THAN 6 HOURS AFTER THE VIAL WAS FIRST PUNCTURED; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced doses that were administered more than 6 hours after the vial was first punctured/ subsequent doses were administered several days later, and vaccine was stored more than 6 hours after the vial was first punctured. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the doses that were administered more than 6 hours after the vial was first punctured/ subsequent doses were administered several days later and vaccine was stored more than 6 hours after the vial was first punctured was not reported. This report was non-serious.
Day one:  swelling of lymph nodes underarm , sensitive to touch underarm;  fatigue;   Day two:  swelling of lymph nodes underarm & collar bone, sensitive to touch collar bone Day three:  swelling reduced underarm & collar bone;  sensitive to touch collar bone Day four:  swelling further reduced underarm;  swelling collar bone same;  no sensitivity to touch
swelling of rt side of face w/in 25 to 30min of inj; had same rxn 13APAR95 to lt sid eof face; ?rxn to HIB
Headache, fever, vomiting, and severe ataxia. Hospitalized for 28 days and given supportive care. CSF had elevated WBC's but was negative for enterovirus and HSV. Also bacterial cultures were negative. Enterovirus only isolated from respiratory panel. At time of discharge patient had returned to baseline. Unsure if will have complete resolution of symptoms.
neurological symptoms; difficult to drive and manage work/life; motion sickness; dizziness; headaches; This is a spontaneous report from a contactable nurse (patient). A 61-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 12Jan2021 (at the age of 61 years old) as dose 2, single for COVID-19 immunisation. Medical history included rheumatoid arthritis, allergies to penicillin, autoimmune disorder (have existing auto immune condition), shingles (has shingles 18 months ago which affected the vestibular and ocular nerves). Concomitant medication(s) included losartan (LOSARTAN) taken for an unspecified indication, start and stop date were not reported. Patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 23Dec2020 (at the age of 61 years old) as single for COVID-19 immunisation. Patient did not received other vaccine in four weeks of COVID vaccine. Patient did not have COVID prior to vaccination. The patient experienced neurological symptoms, difficult to drive and manage work/life, motion sickness, dizziness, headaches on 2021. Reported as, after the second dose patient experienced neurological symptoms. It was very difficult to drive and manage work/life. With motion patient have feeling of motion sickness, dizziness, headaches. Patient did not tested for COVID post vaccination. Outcome of all the events were unknown.  Follow-up attempts completed. No further information expected.
Full body twitches; That are painful; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (Full body twitches) and PAIN (That are painful) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included GABAPENTIN, HYDROCORTISONE, LEFLUNOMIDE (FLUDART), CELECOXIB (CELEBREX), MONTELUKAST SODIUM (SINGULAIR), POTASSIUM, RANOLAZINE, DULOXETINE, ACARBOSE and OMEPRAZOLE for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE TWITCHING (Full body twitches) and PAIN (That are painful). At the time of the report, MUSCLE TWITCHING (Full body twitches) and PAIN (That are painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication also included Methyl Carbinol and Piperamide for unknown indication. No treatment information was provided.
Vaccine sight healed. Weeks later muscle aches like someone punched my arm. lasted two days. Went away for a day then came back for one day.
She said she cannot feel her face at all; She had numbness in her face and her arm; cannot feel her face at all;  left side her face she felt numbness; This is a spontaneous report received from a contactable Pharmacist. A 39-year-old female patient received first dose of BNT162B2 (COMIRNATY, Solution for injection, Lot number and Expiration date was not reported), via an unspecified route of administration, in upper left arm, on 12May2021, as a first dose, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. She said she did not take Prior vaccine within 4 weeks. She does not have any health condition and did not take any like medication. On 12May2021, Pharmacist stated, "So, she reported that she had numbness in her face and her arm after the first vaccine for about two hours. She said she cannot feel her face at all she got her shot on the left side upper arm and then also just left side her face she felt numbness." Pharmacist stated, I do not have lab data information. Pharmacist stated, "I do not know where she got her first vaccine, I do not have any of her first vaccine information because she did not get from us." Reporter seriousness for she had numbness in her face and her arm; cannot feel her face at all; left side her face she felt numbness was reported as unspecified. Outcome of the event numbness in her face and her arm was reported as recovered on n unknown date and outcome of the event cannot feel her face at all was unknown.  Information about lot/batch number has been requested.
Chickenpox; This spontaneous case was reported by a consumer and describes the occurrence of VARICELLA (Chickenpox) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VARICELLA (Chickenpox). At the time of the report, VARICELLA (Chickenpox) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment medications were reported. People that had COVID after vaccine they seem to had more side effects especially with moderna. Also lady never had chicken pox as kid and now had chicken pox since april and doctor said they may never go away.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Got my second dose of Pfizer, 12 hrs later developed  fever (103 F), chills, myalgia, headache. Fatigue, bilateral orbital pain. No visual problems. Took Tylenol every 4 hrs and fever (101. 5)returns in 1-2 hrs. Pulse ox remained normal, 98%, but pulse was 99/min. Usually my resting pulse ox is 55/minutes.  Was unable to go to work and see patients.  Had these symptoms for 48 hrs even though stayed in bed, took Tylenol around the clock and drank plenty of fluids (2-3 liters of water in addition to natural orange and apple juices). Never lost appetite either, do eating my vegetables and fish diet. Ice cream help between Tylenol?s. Completely resolved after 72 hrs. Now still have  LEFT  injection site tender deltoid and left axillary tender nodes, improving as well. All along breathing fine, no cough or congestion or sore throat. No anosmia  or dysgeusia.  This was after my second Pfizer dose.  After the First dose only had tenderness on the RIGHT deltoid muscle injection site and tender axillary node, resolved by now.
Starting the week of April 10th, I thought I had a cold. I was around a new baby that had a cold which triggered my asthma then the next week I went to the doctor. She gave me standard treatment, but it didn?t work went back and was given a stronger dose and it didn?t work. I then decided something wasn?t right, nobody ever suggests COVID. May 2nd, I went to the local ER and they discovered blood clots. I was in the hospital overnight and discharged on the 3rd. Based off all the question they said I had COVID-19 since they found blood clots. The questions they gave never matched with me having blood clots without the possibility of COVID-19. I was found to have PE along with the blood clots I was tested on May 2nd which was positive.
Myalgia, Fever, chills Narrative: fever (101.7), chills, bodyache 1 day post vaccine. Fever resolved after 24 hours
Extreme fatigue/tiredness Fever Upset stomach  Headache  Couldn?t concentrate Weak Chills  Was extremely tired with the first dose also, for three days
Arm injection site pain; Chills; Fever (100F); Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 06May2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included olmesartan medoxomil (MANUFACTURER UNKNOWN) taken for an unknown indication from an unknown date and unknown if ongoing. On 06May2021, the patient experienced arm injection site pain, chills, fever (100F) and fatigue. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 06May2021, the patient underwent body temperature test and the result was 100 Fahrenheit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm injection site pain, chills, fever (100F) and fatigue was resolved on an unknown date in May2021.  No follow-up attempts are possible. No further information is expected.
Patients received the Moderna Covid 19 vaccine after temperature excursion; Patients received the Moderna Covid 19 vaccine after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid 19 vaccine after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the Moderna Covid 19 vaccine after temperature excursion) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 25-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 25-May-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid 19 vaccine after temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the Moderna Covid 19 vaccine after temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid 19 vaccine after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the Moderna Covid 19 vaccine after temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The reporter stated that the facility where she worked, there had been temperature excursions with freezer. It had been happening for weeks since April 2022. The batch numbers were reported as 065K21A and 045L21A. The storage condition at the time of the excursion was reported as frozen storage. The temperatures excursion range was reported as maximum 30 Fahrenheit degrees and minimum minus 18.9 Fahrenheit degrees. The vaccines suffered 2 temperature excursions since April, both lasted less than 1 minute. The vails were stored in frozen state. The visual inspection noting any vaccine state change was reported as no.  No treatment information was reported.
I had fever 100.8 and then it went to 104.7.  I took a fever reducer for 2 1/2 days.
Patient complained of severe lightheadedness, tunnel vision, ringing of the ears, and sweating. History of syncopal episodes with blood draws/shots. Denies shortness of breath, denies swelling of face/throat. Felt better 2 minutes after she was assisted to supine position. Vitals signs stable.
Arm very red and swollen. Tender to touch. PT slept x 48 hrs.
01/13/21 - Employee was awakened approx 2AM with chest discomfort that radiated into her back.
Patient had chest pain post administration of vaccine.  Patient attributed this to heartburn after eating a large meal just before getting her vaccine (though she didn't typically get heartburn). Since the pain continued to persist her BP was taken and was 160/110.  Patient said it may also be nerves but she didn't feel particularly anxious.  She also stated she hadn't had her BP medication that morning.  Patient took a couple of Tums and her BP was rechecked a few times.  Each time the BP stayed above what the patient said was her normal even without BP medication.  Due to the persistence of her hypertension and chest discomfort she was taken to the ED to be evaluated.  Once patient was in ED she had an EKG, CBC with diff, CMP, and troponin.  Provider eventually ruled it as an anxiety reaction (not cardiac related).
PT STATED THEY GOT LIGHT HEADED ABOUT 45 MINUTES AFTER THE SHOT AND STARTED SNEEZING AND HAVING A RUNNY NOSE
Patient came to us with complaints of her heart racing, feeling like she needed "fresh air" and slight itch to throat.  NP and RN on sight assessed patient and had her sit in reclining chair with some water.  50 mg of Benadryl were administered orally at 1630.  By 1720 patient was feeling better and her husband came to pick her up
The second was administered on 2/23/2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 64-year-old male patient who received Herpes zoster (Shingrix) (batch number 5592T, expiry date 12-OCT-2023) for prophylaxis.   Previously administered products included Shingrix (first dose received on October 2021).   On 23-FEB-2023, the patient received the 2nd dose of Shingrix. On 23-FEB-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: The second was administered on 2/23/2023). The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK receipt date: 18-April-2023 The pharmacist reported that the patient received Shingrix first dose on October 2021 but the second dose was administered on 23 February 2023. The reporter did not consent to follow up. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule.
Fever was 102; This case was reported by a consumer via call center representative and described the occurrence of fever in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE for prophylaxis.   On 15th October 2019, the patient received the 1st dose of Shingrix (intramuscular) and PNEUMOCOCCAL VACCINE. On 16th October 2019, 1 days after receiving Shingrix and an unknown time after receiving PNEUMOCOCCAL VACCINE, the patient experienced fever. On 17th October 2019, the outcome of the fever was recovered/resolved.   The reporter considered the fever to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not applicable for this report. In afternoon, the patient stated she got the shot.  When she woke up the next morning, her fever was 102 degree C.  It stayed that way all day then the next day, she was fine.  She later mentioned she had a pneumonia vaccine the same day of her Shingrix shot but had not considered that her fever may have been caused by that vaccine. The reporter did not consented to follow up.  She saw no need to provide her doctor's information. The reporter considered the fever to be related to PNEUMOCOCCAL VACCINE .